Clinical review report Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
The objective of this review is to evaluate the beneficial and harmful effects of Tiotropium bromide monohydrate plus olodaterol hydrochloride (TIO/OLO) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa, Ontario :
Canadian Agency for Drugs and Technologies in Health
2015.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820281506719 |
| Sumario: | The objective of this review is to evaluate the beneficial and harmful effects of Tiotropium bromide monohydrate plus olodaterol hydrochloride (TIO/OLO) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. |
|---|---|
| Descripción Física: | 1 online resource (1 PDF file (xx, 98 pages)) : illustrations |
